Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

354 recalls, newest first

Class I · High risk

Docetaxel Injection

Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.

Ongoing Particulate / foreign matter Sagent Pharmaceuticals NDC 25021-254-08 D-0554-2024
Class I · High risk

Docetaxel Injection

Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.

Ongoing Particulate / foreign matter Sagent Pharmaceuticals NDC 25021-254-08 D-0553-2024
Class II · Moderate risk

suntegrity

CGMP Deviations

Ongoing cGMP deviation Synchronicity Spa INC, Dba Sunte D-0589-2024
Class I · High risk

suntegrity

Microbial Contamination of Non-Sterile Products: Presence of Aspergillus Sydowii (Mold)

Ongoing Microbial contamination Synchronicity Spa INC, Dba Sunte D-0588-2024
Class III · Low risk

Pregabalin Capsules 50mg

Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as pantoprazole tablet 20mg.

Ongoing Particulate / foreign matter Rising Pharma Holding, Inc. NDC 64980-411-10 D-0541-2024

Recalls by year